The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM&C Saatchi Regulatory News (SAA)

Share Price Information for M&C Saatchi (SAA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 195.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.50 (1.279%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 195.50
SAA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading,Banking,Strategy update and results timing

28 Jul 2020 07:00

RNS Number : 2280U
M&C Saatchi PLC
28 July 2020
 

Trading Update and Banking Facilities and Update on 2019 Results

Half Year trading update

Further to the announcement on 30 June 2020, the Company expects to report a small underlying profit before tax (PBT), before exceptional costs, for the 6 months ended 30 June 2020.

Performance was particularly resilient in Q2, driven by continued growth in the World Services division and robust new business performance across sectors and geographies. New assignments include those from TikTok, BP, Bayer, and Tele2. Major government initiatives include the new launch of the better health campaign for Public Health England (UK), the Victoria State Government (Australia) in its fight against COVID-19, and the much talked about Iceland Tourism campaign.

Given the uncertain global economic environment over the last few months, these initial results are encouraging and more favourable than management's expectations. Although revenue declined in H1 2020 compared to H1 2019, the better than expected second quarter performance and the swift and decisive action taken in reducing costs has resulted in a relatively stable first half year performance, stronger than was anticipated at the start of the pandemic.

Our half year results will be announced in September as usual.

Cash position and banking facilities 

The Group's balance sheet remains strong, and has improved further since the announcement on 30 June 2020, with total cash at £59m as of 23 July 2020, compared to £52m as of 23 June 2020. The Group has a committed £36m revolving credit facility (RCF) and a £5m overdraft facility with NatWest. The RCF is fully drawn and the overdraft remains undrawn, leaving net cash of £23m, compared to £16m on 23 June 2020.

In addition to its existing facilities, the Company has received approval for £7m in funding through the UK Government's Coronavirus Large Business Interruption Loan Scheme ("CLBILS"). Given the current cash balance and existing headroom, securing the additional funding is an entirely precautionary measure aimed at ensuring the Company has sufficient cash balances to continue to operate under any plausible trading scenario. The additional headroom from the CLBILS facility is not expected to be drawn in the current trading environment.

Finally, we have also agreed a relaxation of the Company's banking covenants with NatWest for the period from 31 December 2020 to the end of the term of the agreement on 30 June 2021. The table below illustrates the agreed covenant requirements

Covenant Test

Current test ratio requirement

Test ratio requirement from 31st December 2020 onwards

Interest Cover (Ratio of PBIT to Borrowing Costs)

5x or more

4x or more

Ratio of Debt to Earnings

2.5x or less

3.5x or less

We are confident the company can comfortably satisfy its existing covenants for the next quarterly testing period, which falls on 30 September 2020, without needing any alteration. The Company has taken the prudent and precautionary measure of relaxing the covenants for further testing periods after that date, mitigating potential risks that could arise even under an extremely severe scenario.

Update on announcement of audited financial results for the year end 31 December 2019

As previously announced, we were granted a 3 month extension to the filing deadline for the audited financial results for the year ended 31 December 2019 from AIM Regulation such that we need to publish our results by the end of September 2020.

We had targeted the end of July to publish our results, but as a result of disruptions to working practices caused by the COVID-19 pandemic, the Group now expects to announce its full year results for the year ended 31 December 2019 before the end of August 2020.

 

--- end---

 

For further information please call:

M&C Saatchi +44 (0)20-7543-4500David Kershaw, Mickey Kalifa

 

Tulchan Communications +44 (0)20-7353-4200Tom Murray

 

Numis Securities +44 (0)20-7260-1000Nick Westlake, Hugo Rubinstein, NOMADCharles Farquhar, Corporate Broking

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFDLLLBDLFBBQ
Date   Source Headline
22nd Apr 20242:49 pmRNSDirector and PDMR Shareholding
17th Apr 20242:15 pmRNSHolding(s) in Company
16th Apr 202411:43 amRNSPublication of audited ARA and Notice of AGM
11th Apr 20247:00 amRNSAppointment of joint Global CCOs
10th Apr 20247:00 amRNSFull Year Results
9th Apr 20244:22 pmRNSDivestment of South Africa Group subsidiaries
2nd Apr 20243:24 pmRNSDivestment of Associates
25th Mar 20247:36 amRNSHolding(s) in Company
11th Mar 20249:00 amRNSNotice of Results
8th Mar 202411:01 amRNSHolding(s) in Company
22nd Feb 20247:00 amRNSDirectorate Change
30th Jan 20244:55 pmRNSHolding(s) in Company
23rd Jan 20243:11 pmRNSHolding(s) in Company
22nd Jan 20247:00 amRNSConfirmation of Director Appointment
18th Jan 20247:00 amRNS2023 Full Year Trading Update
22nd Dec 20237:00 amRNSDivestment of subsidiaries
14th Dec 20233:31 pmRNSUpdate in relation to 2023 Annual General Meeting
22nd Nov 20232:22 pmRNSHolding(s) in Company
26th Sep 20237:00 amRNSDirector and PDMR Shareholding
18th Sep 202311:43 amRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSM&C Saatchi – 2023 Interim Results
6th Sep 20237:00 amRNSNotice of Interim Results
24th Aug 20234:18 pmRNSTR-1: Notification of major holdings
3rd Aug 20237:00 amRNSGrant of Long-Term Incentive Plan Award
24th Jul 20237:00 amRNSM&C Saatchi - Board Changes
15th Jun 20237:00 amRNSConfirmation of Director Appointments
14th Jun 20234:00 pmRNSResult of Annual General Meeting
14th Jun 20237:00 amRNSM&C Saatchi AGM Trading Update
25th May 20237:00 amRNSTR-1:Standard form-notification of major holdings
15th May 20234:19 pmRNSStandard form for notification of major holdings
15th May 202312:11 pmRNSNotice of Annual General Meeting
24th Apr 20237:00 amRNSShare Purchase by Incoming Chair
18th Apr 20237:00 amRNSAudited Results Full Year 2022
12th Apr 20231:03 pmRNSM&C Saatchi - Confirmation of Director Appointment
3rd Apr 20234:33 pmRNSTR-1: Notification of Major Holdings
30th Mar 20233:05 pmRNSM&C Saatchi Proposed Board Changes
24th Mar 20237:00 amRNSStandard form for notification of major holdings
24th Feb 20237:00 amRNSStandard form for notification of major holdings
8th Feb 20237:38 amRNSCapital Markets Day
8th Feb 20237:00 amRNSM&C Saatchi Capital Markets Day
24th Jan 20237:00 amRNS2022 FY Trading Update and Proposed Board Change
13th Dec 20227:00 amRNSGrant of Long-Term Incentive Plan Awards
15th Nov 20224:37 pmRNSDirectors’ and PDMRs’ Shareholding
2nd Nov 20227:00 amRNSNotice of Capital Markets Day
31st Oct 20222:32 pmRNSForm 8.3 - Next Fifteen Communications Group Plc
31st Oct 202212:53 pmRNSResponse to Outcome of M&C Saatchi Meetings
31st Oct 202212:16 pmRNSResults of Court Meeting and General Meeting
26th Oct 20223:00 pmGNWForm 8.3 - Octopus Investments - M&C Saatchi plc
26th Oct 20222:39 pmRNSForm 8.3 - NEXT FIFTEEN COMMUNICATIONS GROUP PLC
25th Oct 20222:29 pmRNSForm 8.3 - Next Fifteen Communications Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.